AMDX-2011P

DRUG3 trials

Sponsors

Amydis Inc.

Conditions

Alzheimer DiseaseCerebral Amyloid AngiopathyPrimary Open Angle Glaucoma

Phase 2

A Study of AMDX-2011P in Participants With CAA

RecruitingNCT05709314

Amydis Inc.Cerebral Amyloid Angiopathy

Start: 2024-07-09End: 2026-12-01Target: 25Updated: 2026-02-13

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

RecruitingNCT06223048

Amydis Inc.Primary Open Angle Glaucoma

Start: 2023-12-07End: 2025-02-28Target: 50Updated: 2024-07-30

A Study of AMDX-2011P in Participants With Alzheimer's Disease

RecruitingNCT06514001

Amydis Inc.Alzheimer Disease

Start: 2025-03-07End: 2027-08-01Target: 25Updated: 2026-08-31